50
Participants
Start Date
April 17, 2020
Primary Completion Date
September 30, 2020
Study Completion Date
October 30, 2020
Favipiravir
Favipiravir to be administered as an oral tablet or made into a slurry for subjects who cannot swallow tablets
Standard of Care
Standard of Care for individual study site as determined by each hospital's protocol
University of Miami Miller School of Medicine, Miami
Houston Methodist Hospital, Houston
HonorHealth, Scottsdale
Boston Medical Center, Boston
Brigham and Women's Hospital, Boston
Massachusetts General Hospital, Boston
UMass Memorial Health Care, Worcester
Atlantic Health System / Morristown Medical Center, Morristown
Lead Sponsor
Fujifilm Pharmaceuticals U.S.A., Inc.
INDUSTRY